Revvity, Inc. (RVTY) is a Technology stock trading at $99.94 (as of 2026-06-18), with a market capitalization of $11.66B and a trailing P/E of 50.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Revvity, Inc. develops products and services for diagnostics and life sciences, including instruments, reagents, assay platforms, and related software and informatics for research, analytical testing, and early detection of genetic and infectious disease. It operates through Discovery & Analytical Solutions and Diagnostics segments, serving customers worldwide across laboratory, research, and applied analysis markets.